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Objective: To explore the mechanism of electroacupuncture (EA) in improving ischemic stroke. Methods:
The Wistar rat model of focal cerebral ischemia-reperfusion was prepared by the thread embolism method. 
The rats were randomly divided into a normal group, a model group, and an EA group. EA was given at 
bilateral “Hegu” (LI 4) in rats of the EA group. Expression of the vascular endothelial growth factor (VEGF) 
mRNA was detected with hybridization in situ, and expressions of the angiogenin-1 (Ang-1) and endostatin 
proteins were detected with the immunohistochemical method. Results: As compared with the normal group, 
the expressions of VEGF mRNA, Ang-1 protein and endostatin protein significantly increased in the model 
group (all P<0.05); and when compared with the model group, the EA group showed even more significant 
increase in expressions of the VEGF mRNA and Ang-1 protein (both P<0.05), but with an obvious decline in 
the increase of expression of endostatin protein (P<0.05). Conclusions: EA can promote angiogenesis in 
brain of experimental cerebral ischemic rats after reperfusion probably through up-regulating the expression 
of angiogenesis factors and down-regulating the expression of anti-angiogenesis factors. 
After cerebral ischemia, restoring blood supply to the 
ischemic region as quick as possible to save the dying 
neurons, neuroglial cells and vascular endothelial 
cells is the key link for treatment of ischemic 
cerebrovascular diseases. In the past, the relevant 
researches were stressed on the neurons with less 
attention paid to the vascular endothelial cells. In fact, 
besides the conventional methods, such as dilating 
the blood vessels, the anti-coagulant therapy and the 
thrombolytic therapy, the measures taken for 
stimulating the genesis of blood capillaries may open 
up a new way. After focal cerebral ischemia, the 
newly formed collateral blood vessels can obviously
improve perfusion of the surrounding tissues, and can 
promote recovery of the nervous functions.1 The 
studies of recent years have found that dynamic 
changes of the angiogenesis factors and anti- 
angiogenesis factors may jointly influence formation 
of the new blood vessels after cerebral ischemia. The 
present study is designed to investigate the focal 
cerebral ischemia-reperfusion and electroacupuncture 
(EA) on expressions of the vascular endothelial 
growth factor (VEGF), angiogenin (Ang-1) and 
endostatin in the rat brain, and to observe dynamic 
changes of the angiogenesis factors and anti- 
angiogenesis factors, so as to further expound the 
mechanism of EA for improving ischemic stroke. 
MATERIALS AND METHODS 
Grouping of the animals 
The rats were randomly divided into a normal group 
(n=6), a focal cerebral ischemia-reperfusion model 
group (model group, n=42), a focal cerebral 
ischemia-reperfusion plus electroacupuncture group 
(EA group, n=42). The latter two groups were 
respectively subdivided into the 2-h, 12-h, 24-h, 3-d, 
7-d, 14-d and 21-d reperfusion groups (n=6) after 1-h 
focal cerebral ischemia. No any treatment was given 
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to the rats of the normal group. 
Preparation of the rat model 
Ninety adult male healthy Wistar rats, weighing 
250-300 g, were supplied by the Center for Exper- 
imental Animals, Daping Hospital, the Third Military 
Medical University (Certificate No:SCXK 20020002). 
The focal cerebral ischemia-reperfusion rat model 
was prepared by thread embolism of the right middle 
cerebral artery. The rats were anesthetized with intra- 
peritoneal injection of 3.5% chloral hydrate (1 mL/
100 g body weight) and fixed in a dorsal position. 
Then, the common carotid artery, external carotid 
artery and the extracranial segment of the internal 
carotid artery were exposed in order via a medial 
incision on the neck. A ring-shaped incision was 
made at the end of external carotid artery, and a 
polyurethane-treated embolus nylon thread in a 
diameter of 0.23 mm was inserted 17-20 mm deep 
into the intracranial segment of the internal carotid 
artery. A feeling of resistance indicated that the thread 
thrombus head had reached the starting part of the 
middle cerebral artery with the occurrence of cerebral 
ischemia. One hour later, the thread thrombus was 
withdrawn to the end of the external carotid artery, 
and reperfusion was realized.  
Stimulation methods and parameters of EA 
In the EA group, bilateral “Hegu” (LI 4) were 
selected in reference to The Acupoint Atlas for 
Experimental Animals drawn by The Experimental 
Acupuncture and Moxibustion Committee, Chinese 
Association of Acupuncture and Moxibustion. 45 min 
after focal cerebral ischemia, EA was given at 
bilateral “Hegu” (LI 4) for 15 min each time. In the 
groups with reperfusion for over 1 day, EA was given 
once a day for 7 days at most. After that, the rats 
were fed naturally with no special treatment given. 
EA stimulation parameters: the sparse-dense wave 
F1=40 Hz, F2=60 Hz, and no-load output voltage 
1.5V. 
Sampling 
At the stipulated reperfusion time for each group, the 
rats were anesthetized, the left ventricle was rapidly 
washed by perfusion of 200 ml saline, and fixed with 
rapid and then slow perfusion of 500 ml 4% 
paraformaldehyde plus 0.1% DEPC, followed by 
decapitation with the brain taken and the paraffin 
sections prepared. The surrounding tissues of the 
ischemic region were observed and the adjacent 
sections were taken respectively for hybridization in 
situ and immuneohistochemical examination, 
Detection of VEGF mRNA with hybridization in 
situ 
The VEGF mRNA in situ hybridization kits used 
were made by Wuhan Boshide Company. Processing 
of the pre-hybridization: After deparaffin, the 
sections were processed with a 3% citric acid-pepsin 
solution for 3 min, and then fixed with 1% para- 
formaldehyde (prepared with pH7.4 0.1 mol/L PBS, 
added with 0.1% DEPC).  Hybridization: Drip 
pre-hybridization solution for a 6-h pre-hybridization 
at 39ć , and then drip appropriate amount of 
hybridization solution, cover with an in situ 
hybridization coverslip to keep overnight at 41ć. 
Washing after hybridization: Wash with 2XSSC, 
0.5XSSC, 0.2XSSC, respectively. Drip the blocking 
solution, the biotinylated rat anti-digoxin antibody, 
SABC, and the biotinylated peroxidase in order, 
followed by DAB coloration, dehydration, clearing 
and mounting. 
Immunohistochemical examination of Ang-1 and 
endostatin proteins 
After deparaffin of the sections, antigen heat repair 
for 15 min at 92-98ć, drip blocking solution, drip 
respectively 1: 100 rabbit anti-rat Ang-1 antibody 
(Wuhan Boshide Company) and 1:100 rabbit anti-rat 
endostatin antibody (Wuhan Boshide Company) to 
keep overnight at 4ć, and drip SABC, followed by 
DAB coloration, dehydration, clearing and mounting.
Judgment and statistical processing 
Count the positive cells under visual field (X400). 
The cells with cytoplasma stained brown-yellow was 
regarded as the positive ones. 3 non-continuous 
sections were randomly selected from each rat, and 
the mean of 10 non-continuous visual fields taken 
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from each section was recorded. The data were 
expressed as x fs, the Excel software was used for 
t-test, and P<0.05 was regarded as the statistically 
significant difference. 
RESULTS 
VEGF mRNA in situ hybridization 
In the normal group, a few positive cells were found 
in the cortex, internal capsule, and hippocampus. In 
the model group, VEGF mRNA expression 
significantly increased 2h after reperfusion (P<0.01) 
and reached to the peak 24h after reperfusion 
(P<0.01), which was still kept at a high level 7d after 
reperfusion (P<0.01). The diffuse distribution of the 
positive cells was found in the cortex round the 
ischemic necrotic region. And the brown-yellow 
cytoplasma was found in the nerve cells and vascular 
endothelial cells of the lateral ventricle and the 
dentate gyrus of hippocampus. As compared with the 
model group, VEGF mRNA increased more 
significantly in the EA group 2h, 12h after 
reperfusion (P<0.01) and reached to the peak 24h 
after reperfusion (P<0.01); and it still showed a 
statistically significant increase 14d after reperfusion 
(P<0.05). See Table 1. 
Table 1. The vascular VEGF mRNA expressions ( x fs) 
Groups n 2h 12h 24h 3d 7d 14d 21d 
Normal 6 4.08±0.85 - - - - - - 
Model 6  7.22±1.32* 14.42±3.44* 25.23±4.22* 20.29±3.45* 11.24±2.56* 7.47±1.72* 3.92±0.24
EA 6 13.23±4.32*#  31.25±2.92*# 40.63±5.14*# 35.98±3.17*# 16.92±2.45*# 10.01±2.14*∆ 4.03±1.08
Note: As compared with the normal group, *P<0.01; as compared with the model group, #P<0.01, ∆P<0.05. 
Immunohistochemical detection of Ang-1 protein 
In the normal group, there was almost no the 
expression of positive cells in the brain tissue. In the 
model group, the Ang-1 protein expression was not 
significantly different to that of the normal group 2h 
and 12h after reperfusion (P>0.05); but it increased 
24h after reperfusion (P<0.01), reached to the peak 
14d after reperfusion (P<0.01), and did not return to 
the normal range 21d after reperfusion (P<0.05). The 
expression significantly increased in the cortex round 
the ischemic necrosis region. The choroids of lateral 
ventricle, ependymal cells and cytoplasma of 
endothelial cells of the peripheral small blood vessels 
were blown-yellow in color. A great number of 
neurons and gliocytes in the dentate nucleus of 
hippocampus showed very strong positive 
expression.  
In the EA group, the Ang-1 protein expression 
increased from 2h to 21d after reperfusion as 
compared with that of the normal group, and it 
showed even more significant increase as compared 
with that of the model group, (the expression 
positions were same as those of the model group). As 
compared with the normal group, the expression 
began to increase 2h after reperfusion (P<0.05), it 
even more significantly increased 12h after reper- 
fusion (P<0.01), and still kept a higher level 21d after 
reperfusion (P<0.01). When compared with the 
model group, it significantly increased 2h after 
reperfusion (P<0.05) and reached to the peak 14d 
after reperfusion (P<0.01), and still showed a 
significant difference 21d after reperfusion (P<0.05). 
See Table 2. 
Immunohistochemical detection of endostatin 
protein 
In the normal group, a less expression of endostatin 
protein was found in the hippocampus and striatum. 
In the model group, the endostatin protein expression 
began to increase 2h after reperfusion (P<0.01), 
reached to the peak 12h after reperfusion (P<0.01), 
and still showed significant difference 3d after 
reperfusion (P<0.01), but with no obvious difference 
7d after reperfusion (P>0.05). The endostatin protein 
was expressed mainly in the ischemic penumbra, 
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including the surroundings of lateral ventricle, 
hippocampus and striatum, but with a less expression 
in the cortex; and it was expressed mainly in the 
vascular endothelial cells, but with less expression in 
the nerve cells.  
As compared with the normal group, in the EA group, 
the endostatin protein expression increased 2h after 
reperfusion (P<0.01), but the increase was much 
lower and with no significant difference 3d after 
reperfusion (P>0.05). When compared with the 
model group, the endostatin protein expression was 
significantly inhibited within 3d after reperfusion, 
and it still showed a declining tendency in the 
following days though there was no obvious 
difference (P>0.05). See Table 3. 
Table 2. The Ang-1 protein expressions ( x fs) 
Groups n 2h 12h 24h 3d 7d 14d 21d 
Normal 6 5.15±1.03 - - - - - - 
Model 6 5.72±0.75 6.32±1.72  8.72±2.31** 10.37±2.53** 13.08±2.93** 20.19±3.12** 8.15±2.45* 
EA 6 7.23±1.24*∆ 8.92±2.50** 11.42±2.32** 18.72±3.17**# 17.14±2.45**∆ 28.17±4.54**# 11.22±1.57**∆
Note: As compared with the normal group, **P<0.01, *P<0.05; as compared with the model group, #P<0.01, ∆P<0.05. 
Table 3.The endostatin protein expressions ( x fs) 
Groups n 2h 12h 24h 3d 7d 14d 21d 
Normal 6 4.15±1.97 - - - - - - 
Model 6 24.82±4.06* 28.64±3.17* 23.30±3.05* 15.79±3.26* 5.32±1.45 3.72±1.33 4.09±2.17 
EA 6 14.52±1.33*# 21.32±3.24*# 15.61±5.17*∆  6.51±2.55# 3.45±1.62 4.05±2.15 3.81±1.86 
Note: As compared with the normal group, *P<0.01; as compared with the model group, #P<0.01, ∆P<0.05. 
DISCUSSION 
Expression of the angiogenesis factors  
Angiogenesis after cerebral ischemia can be 
regulated by a series of angiogenesis factors and 
anti-angiogenesis factors. The angiogenesis factors, 
including specific VEGF family and Ang family of 
the endothelial cells, have the positively regulative 
action. 2 They are interrelated each other and jointly 
regulate various links of angiogenesis. The VEGF/ 
VEGFR system may possibly play a key role in 
initiating angiogenesis and is the central link for 
regulating and controlling angiogenesis after cerebral 
ischemia. VEGF is a specific mitogen and chemo- 
tactic factor of the endothelial cells. 3 In the present 
study, the expression of angiogenesis factors 
increased after cerebral ischemia. VEGF mRNA 
began to increase 2h after reperfusion, reached to the 
peak 24h after reperfusion, and still showed 
significant difference 14d after reperfusion; while 
Ang-1 protein began to increase 24h after reperfusion, 
reached to the peak 14d after reperfusion, and did not 
return to the normal range 21d after reperfusion. It is 
indicated that VEGF may possibly play a role mainly 
at the early stage and metaphase, while Ang-1 show 
the effect at the metaphase and later stage, with a 
crossed and overlapped acting time. The activity of 
Ang-1 began to increase later than that of VEGF, 
which may help to increase branches of the blood 
vessels, and promote the remodeling, maturity and 
stability of blood vessels. 4 The different time for 
VEGF and Ang-1 expressions may be the process for 
VEGF to activate endogenous angiogenesis at the 
early stage of cerebral ischemia with the increase of 
vascular permeability and the destruction of blood-
brain barrier function; while Ang-1 has an inhibitory 
action on migration of the nascent endothelium, it 
mediates maturity of the blood vessels and prevents 
the blood-brain barrier from being over destroyed. 
As compared with the model group, in the EA group, 
VEGF mRNA increased 2h after reperfusion, reached 
to the peak 24h after reperfusion, and still showed a 
statistically significant difference 14d after reper- 
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fusion, indicating that the increase of VEGF mRNA 
was more obvious in the EA group and lasted longer. 
Ang-1 protein in the EA group showed a significance 
increase 2h after reperfusion as compared with that of 
the normal group; and when compared with the 
model group, in the EA group, Ang-1 protein began 
to increase 2h after reperfusion, reached to the peak 
14d after reperfusion, and still showed significant 
difference 21d after reperfusion, indicating that 
Ang-1 protein increased earlier and more obviously 
in the EA group. Most of the previous studies on 
focal cerebral ischemia-reperfusion were aimed at the 
early stage. In the present study, the period of 
experiment was prolonged to 21 days, so we can see
a whole process of the expressions for angiogenesis 
factors. And the EA stimulation was given only for 7 
days at most, but the expression level of angiogenesis 
factors was still higher than that of the model group, 
showing a lasting effect of EA. 
In the present study, the expressions of VEGF and 
Ang-1 were found mainly around the ischemic 
regions involving both the nerve cells and the 
vascular endothelial cells, indicating that the 
angiogenesis factors may possibly act simultaneously 
on the nerve cells and the vascular endothelial cells, 
mediating the interaction of nerves and blood vessels, 
and playing an important role in repair of the nerve 
system and the blood vessel system after cerebral 
ischemia. The “nerve-vessel unit” is mainly 
composed of the nerve cells, the vascular endothelial 
cells, the astrocytes, and their surrounding 
extracellular matrixes as well, 5 which should be 
comprehensively considered for treatment of cerebral 
ischemia. This concept emphases the interaction and 
dynamic balance between the cells, and between the 
cells and matrixes, comprehensively reflecting the 
pathological and physical processes for cerebral 
ischemia. Whether or not the actions of VEGF and 
Ang-1 are correlated with the “nerve-vessel unit”, 
and how the EA stimulation influence the “nerve- 
vessel unit” need to be further studied. 
Expression of the anti-angiogenesis factors 
In the past, in the study of angiogenesis after cerebral 
ischemia, more attention was paid to the angiogenesis 
factors, but not enough to the anti-angiogenesis 
factors. The anti-angiogenesis factors include 
endostatin and angiostatin, which have the negative 
regulating effects to antagonize the action of the 
angiogenesis factors. Endostatin may induce 
apoptosis of the endothelial cells via multiple ways, 6
and it can inhibit proliferation and migration of the 
endothelium and block activation of the VEGF 
receptor. The ability of angiogenesis depends on 
dynamic balance between the angiogenesis factors 
and anti-angiogenesis factors, so regulating the 
balance between them may help promote or inhibit 
the growth of blood vessels. At present, most of the 
studies for endostatin are focused on inhibition of the 
tumor growth. The endostatin expression after 
cerebral ischemia has not been reported yet. In the 
present study, the endostatin expression significantly 
increased 2h after cerebral ischemia and reached to 
the peak 12h after reperfusion in the model group, 
which basically conforms to the time of apoptosis of 
the endothelial cells; but it showed no significant 
difference 7d after reperfusion. Endostatin inhibits 
angiogenesis at the early stage (<24h) after cerebral 
ischemia. The above studies suggest that a decreased 
expression of the anti-angiogenesis factors at the 
early stage (<24h) may possibly contribute to 
angiogenesis. In the EA group, the endostatin protein 
expression increased within 24h after reperfusion 
(P<0.01), but the increase was significantly inhibited 
as compared with the model group (P<0.01 or 0.05), 
indicating that EA can significantly decrease the early 
expression of anti-angiogenesis factors.  
Effects of EA on the angiogenesis factors and 
anti-angiogenesis factors 
The previous studies suggested that EA at “Baihui” 
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(GV 20) and “Shuigou” (GV 26) could stimulate the 
expression of angiogenesis factors after cerebral 
ischemia, and promote the neogenesis of blood 
vessels and the recovery of nervous functions. 7-9 EA 
promoting angiogenesis after cerebral ischemia is 
possibly related with its bidirectional regulating 
effects on expression of the vascular factors, i.e., 
up-regulating the expression of angiogenesis factors 
and down-regulating the expression of anti- 
angiogenesis factors. It is found in the present study 
that after EA, the expression of angiogenesis factors 
was increased, while the expression of anti- 
angiogenesis factors was inhibited.  
At present, for therapeutic angiogenesis, the 
corresponding recombinant proteins or genes are 
usually introduced into the ischemic tissues to 
stimulate neogenesis of the collateral capillary 
vessels. But clinically, it is not easy to control this 
exogenous “supplementary” mechanism. We think 
that EA may possibly activate an endogenous 
angiogenesis with a better regulation and effect. 
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